ATMI Austar LifeSciences

ATMI Austar LifeSciences was a prominent joint venture between the American technology firm ATMI, Inc. and the Hong Kong-based Austar Lifesciences Limited. The company specialized in providing single-use technology (SUT) solutions to the biopharmaceutical industry, with a primary focus on the rapidly growing market in China and the Asia-Pacific region. Its core product offerings included the Integrity line of single-use bioprocess containers, mixing systems, and storage solutions designed for sterile fluid handling in vaccine and monoclonal antibody production. In 2014, the joint venture's operations were effectively integrated into Pall Corporation following Pall's acquisition of ATMI's LifeSciences business unit. This entity played a critical role in introducing advanced single-use manufacturing standards to the Chinese life sciences sector.